Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-012226
Filing Date
2021-05-19
Accepted
2021-05-19 16:06:25
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 746303
2 ex23-1.htm EX-23.1 4400
3 ex31-1.htm EX-31.1 16905
4 ex31-2.htm EX-31.2 16833
5 ex32-1.htm EX-32.1 5939
6 ex32-2.htm EX-32.2 5394
  Complete submission text file 0001493152-21-012226.txt   3014642

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE vbio-20210331.xml EX-101.INS 398801
8 XBRL SCHEMA FILE vbio-20210331.xsd EX-101.SCH 35477
9 XBRL CALCULATION FILE vbio-20210331_cal.xml EX-101.CAL 48210
10 XBRL DEFINITION FILE vbio-20210331_def.xml EX-101.DEF 95090
11 XBRL LABEL FILE vbio-20210331_lab.xml EX-101.LAB 249695
12 XBRL PRESENTATION FILE vbio-20210331_pre.xml EX-101.PRE 191522
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

EIN.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-53832 | Film No.: 21940337
SIC: 8731 Services-Commercial Physical & Biological Research